259 related articles for article (PubMed ID: 16128682)
1. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
2. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine.
Chrzanowska M; Krzymański M
Ther Drug Monit; 1999 Apr; 21(2):231-7. PubMed ID: 10217345
[TBL] [Abstract][Full Text] [Related]
3. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Hoentjen F; Hanauer SB; de Boer NK; Rubin DT
Dig Dis Sci; 2012 Jan; 57(1):250-3. PubMed ID: 22147254
[TBL] [Abstract][Full Text] [Related]
4. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
Lowry PW; Franklin CL; Weaver AL; Pike MG; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Gut; 2001 Nov; 49(5):665-70. PubMed ID: 11600469
[TBL] [Abstract][Full Text] [Related]
5. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
6. Key factors associated with 6-thioguanine and 6-methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.
de Beaumais TA; Lorrain S; Mamhoudi N; Simonin M; Martinez Vinson C; Medard Y; Petit A; Jacqz-Aigrain E
Br J Clin Pharmacol; 2024 Jan; 90(1):209-219. PubMed ID: 37621013
[TBL] [Abstract][Full Text] [Related]
7. HPLC analysis of azathioprine metabolites in red blood cells, plasma and urine in renal transplant recipients.
Weller S; Thürmann P; Rietbrock N; Gossmann J; Scheuermann EH
Int J Clin Pharmacol Ther; 1995 Dec; 33(12):639-45. PubMed ID: 8963480
[TBL] [Abstract][Full Text] [Related]
8. A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy.
Erdmann GR; France LA; Bostrom BC; Canafax DM
Biomed Chromatogr; 1990 Mar; 4(2):47-51. PubMed ID: 2350596
[TBL] [Abstract][Full Text] [Related]
9. If at first you don't succeed...Try again?
Kane S
Am J Gastroenterol; 2001 Jul; 96(7):2260. PubMed ID: 11467666
[No Abstract] [Full Text] [Related]
10. [Use of immunosuppressors in chronic inflammatory intestinal diseases].
Lémann M
Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B178-88. PubMed ID: 10897790
[No Abstract] [Full Text] [Related]
11. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy.
Cuffari C; Hunt S; Bayless TM
Aliment Pharmacol Ther; 2000 Aug; 14(8):1009-14. PubMed ID: 10930894
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters.
Hradsky O; Potuznikova K; Siroka J; Lerchova T; Urbanek L; Mihal V; Spenerova M; Velganova-Veghova M; Karaskova E; Bronsky J
J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):e105-e110. PubMed ID: 31568041
[TBL] [Abstract][Full Text] [Related]
13. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease.
Gupta P; Gokhale R; Kirschner BS
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):450-4. PubMed ID: 11698762
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppressive therapy with antimetabolites].
Gross D
Ther Umsch; 1967 Apr; 24(4):147-53. PubMed ID: 5584943
[No Abstract] [Full Text] [Related]
15. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
de Jong D; Mulder CJ; van Sorge AA
Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
[No Abstract] [Full Text] [Related]
16. Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency.
Deben DS; Derijks LJJ; van den Bosch BJC; Creemers RH; van Nunen A; van Bodegraven AA; Wong DR
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887379
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia.
Kamojjala R; Bostrom B
J Pediatr Hematol Oncol; 2021 Apr; 43(3):95-100. PubMed ID: 33750748
[TBL] [Abstract][Full Text] [Related]
18. Pancytopenia due to the interaction of allopurinol with azathioprine or mercaptopurine.
Prescrire Int; 2000 Apr; 9(46):50. PubMed ID: 11503788
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in inflammatory bowel disease.
Hoang P; Fontaine P; Dalton HR; Gehenot M; Sibille C; Schoonbroodt D; Vanheuverzwyn R
Acta Gastroenterol Belg; 1994; 57(5-6):333-8. PubMed ID: 7709704
[No Abstract] [Full Text] [Related]
20. [Therapy of chronic hepatitis].
Dioguardi N
Minerva Med; 1974 Nov; 65(82):4261-6. PubMed ID: 4431580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
